| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/02/2006 | WO2006010805A2 Novel polypeptides for isolating in vitro and preventing legionella pneumophila infections |
| 02/02/2006 | WO2006010619A1 Method for diagnosing and treating bone-related diseases |
| 02/02/2006 | WO2006010603A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 02/02/2006 | WO2006010533A2 Pancreatic polypeptide as target/marker of beta cell failure |
| 02/02/2006 | WO2006010531A1 Prohormone convertase i as target/marker for beta cell failure |
| 02/02/2006 | WO2006010530A1 Insulin promoter factor 1 as target/marker of beta cell failure |
| 02/02/2006 | WO2006010514A2 Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5) |
| 02/02/2006 | WO2006010499A2 Diagnostics and therapeutics for diseases associated with carboxypeptidase a2 (cpa2) |
| 02/02/2006 | WO2006010498A2 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 (metap2) |
| 02/02/2006 | WO2006010496A1 Diagnostics and therapeutics for diseases associated with dipeptidase 1 (dpep1) |
| 02/02/2006 | WO2006010495A2 Diagnostics and therapeutics for diseases associated with carboxypeptidase a3 (cpa3) |
| 02/02/2006 | WO2006010493A1 Diagnostics and therapeutics for diseases associated with ethanolamine kinase 1 (ek11) |
| 02/02/2006 | WO2006010492A1 Diagnostics and therapeutics for diseases associated with tryptase 1 (tps1) |
| 02/02/2006 | WO2006010489A2 Diagnostics and therapeutics for diseases associated with choline kinase like protein (chkl) |
| 02/02/2006 | WO2006010454A1 Isolated photoprotein aequorin y89f and use thereof |
| 02/02/2006 | WO2006010403A1 Fluorescent phosphonic ester library |
| 02/02/2006 | WO2006010376A1 Method for diagnosing and treating bone-related diseases |
| 02/02/2006 | WO2006010369A2 Methods for determining proteins and protein-bound compounds comprising enzymatic modification |
| 02/02/2006 | WO2005117532A3 Method for improved breast milk feeding to reduce the risk of allergy |
| 02/02/2006 | WO2005114213A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor npy1 (npy1) |
| 02/02/2006 | WO2005114212A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor npy4 (npy4) |
| 02/02/2006 | WO2005112903A3 Use of ghrelin antagonists for improving cognition and memory |
| 02/02/2006 | WO2005111607A3 Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific bonding reactions |
| 02/02/2006 | WO2005107782A3 Use of a modulator of gene expression in the treatment of cancer |
| 02/02/2006 | WO2005106486A3 Diagnostic and therapeutics for diseases associated with dipeptidyl-peptidase 3(dpp3) |
| 02/02/2006 | WO2005098428A3 Method and system for screening compounds for muscular and/or neurological activity in animals |
| 02/02/2006 | WO2005093411A3 Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxigenase and methods of using the same |
| 02/02/2006 | WO2005090988A3 Mycobacterium tuberculosis infection diagnostic test |
| 02/02/2006 | WO2005090966A3 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard) |
| 02/02/2006 | WO2005085861A3 Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer |
| 02/02/2006 | WO2005085818A3 Method and device for the measurement and on-line characterisation of a biomass |
| 02/02/2006 | WO2005084266A3 Functional method for generating or screening for ligands which modulate steroid hormone receptors |
| 02/02/2006 | WO2005081931A3 Nickel-coated free-standing silicon carbide structure for sensing fluoro or halogen species in semiconductor processing systems, and processes of making and using same |
| 02/02/2006 | WO2005077106A3 Monoclonal antibody based biomarker discovery and development platform |
| 02/02/2006 | WO2005070014A3 Enzymatic methionine assay |
| 02/02/2006 | WO2005057220A3 Agents modulating the activity of ccrl2 and methods of using the same |
| 02/02/2006 | WO2005051413A3 Disease associated genes |
| 02/02/2006 | WO2005047245A3 Fluorescence assays with improved blocking groups |
| 02/02/2006 | WO2005046602A3 Vegf receptor antagonists |
| 02/02/2006 | WO2005036127A3 Methods and compositions for identifying target cell cytolytic lymphocytes in a sample |
| 02/02/2006 | WO2005003727A3 Optical sensor for measuring characteristics and properties of strands |
| 02/02/2006 | WO2005003301A3 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms |
| 02/02/2006 | WO2004113503A3 Mbms as modifiers of branching morphogenesis and methods of use |
| 02/02/2006 | WO2004060301A3 Novel compositions and methods in cancer |
| 02/02/2006 | WO2003072068A3 Targeted immunotherapy of acute lymphoblastic leukemia (all) |
| 02/02/2006 | WO2003035006A3 Amyloid ss is a ligand for fpr class receptors |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060026702 Phosphoinositide 3-kinase mediated inhibition of GPCRs |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060025977 Computational method and apparatus for predicting polypeptide aggregation or solubility |
| 02/02/2006 | US20060025933 Method for interpreting tandem mass spectrometry data for clinical diagnosis of genetic disorders such as hypermethionemia |
| 02/02/2006 | US20060025932 Novel method for chromatographic finger printing and standardization of single medicines and formulations |
| 02/02/2006 | US20060025930 Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
| 02/02/2006 | US20060025929 Method of determining a genetic relationship to at least one individual in a group of famous individuals using a combination of genetic markers |
| 02/02/2006 | US20060025928 Hydropathy plots and fourier analysis with an ellipsoidal distance metric |
| 02/02/2006 | US20060025575 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025572 Mammalian cell surface antigens; related reagents |
| 02/02/2006 | US20060025469 Methods for decreasing beta amyloid protein |
| 02/02/2006 | US20060025419 Imidazoquinoxaline compound for the treatment of melanoma |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060025360 Human cervical cancer protooncogene and protein encoded therein |
| 02/02/2006 | US20060025344 Ghrelin receptor inverse agonists for regulation of feeding behaviors |
| 02/02/2006 | US20060025338 Compositions and methods for treatment of lymphatic and venous vessel arterialization |
| 02/02/2006 | US20060025333 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 02/02/2006 | US20060024847 Controlled optoelectronic coupling in nanoparticle arrays |
| 02/02/2006 | US20060024846 Multiplex analysis using membrane-bound sensitizers |
| 02/02/2006 | US20060024845 Efficient immobilization and measuring an interaction of low-molecular compound and high-molecular compound, low-molecular compound and low-molecular compound or high-molecular compound and high-molecular compound, or purifying a target molecule on the basis of a specific interaction |
| 02/02/2006 | US20060024844 Method for the idenification of ligands |
| 02/02/2006 | US20060024843 Assay device |
| 02/02/2006 | US20060024842 rapid assay of antigens, antibodies; pregnancy prognosis |
| 02/02/2006 | US20060024841 Method and apparatus for delivery of submicroliter volumes onto a substrate |
| 02/02/2006 | US20060024839 Inorganic carbon removal |
| 02/02/2006 | US20060024836 Quantitative analysis of nitrogen oxides occluded in heterogeneous catalysis |
| 02/02/2006 | US20060024834 a derivatized 1,3,5 tris-(phenylethynyl)benzene molecule, having fluorescent properties and capable of complexing with an analyte of interest, such as heparin |
| 02/02/2006 | US20060024833 Fluorescent metal ion indicators with large stokes shift |
| 02/02/2006 | US20060024832 Water-soluble derivatives of lipophilic drugs |
| 02/02/2006 | US20060024831 Normalization of data using controls |
| 02/02/2006 | US20060024820 Chromosome-based platforms |
| 02/02/2006 | US20060024813 Nano-mechanic microsensors and methods for detecting target analytes |
| 02/02/2006 | US20060024806 Mycolactone locus: an assembly line for producing novel polyketides, therapeutic and prophylactic uses |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024800 Method of modulating the activity of functional immune molecules |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024791 Method |
| 02/02/2006 | US20060024787 Chimp trace amine associated receptors and polypeptides |
| 02/02/2006 | US20060024785 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 02/02/2006 | US20060024781 Detection of truncation mutations by mass spectrometry |
| 02/02/2006 | US20060024772 Parathyroid hormone antibodies and related methods |
| 02/02/2006 | US20060024771 Enhancing fluorescent signal of labeled immunoglobulin via surrounding fluorophore with nanometal particle in self-assembled monolayer; sandwich immunoassay |
| 02/02/2006 | US20060024770 For quantitative antigen analysis by determining the change in enzymatic activity of an enzyme-labelled antigen or antibody caused by an immunological reaction |
| 02/02/2006 | US20060024769 monoclonal antibodies generated by taxol linked immunogens, used for quantitative analysis and monitoring of taxol in biological fluids |
| 02/02/2006 | US20060024768 monoclonal antibodies generated by taxol linked immunogens, used for quantitative analysis and monitoring of taxol in biological fluids |
| 02/02/2006 | US20060024767 Detection of neurodegradation disease in humans, animals; measuring concentration of prion protein |
| 02/02/2006 | US20060024766 Bifunctional molecules |
| 02/02/2006 | US20060024765 Method of inspecting staphylococcus aureus |
| 02/02/2006 | US20060024764 Proteins producing an altered immunogenic response and methods of making the same |
| 02/02/2006 | US20060024763 Mass spectrometry-based methods for detection and differentiation of botulinum neurotoxins |
| 02/02/2006 | US20060024762 Heteroaryl substituted benzothiazole dioxetanes |